Epigenetic modifications in salivary glands from patients with Sjögren's syndrome affect cytokeratin 19 expression

Auteurs-es

  • O.D. Konsta Brest University Medical School
  • A. Charras Research Unit EA2216 Immunology, Pathology and Immunotherapy, SFR ScinBios and Labex Igo “Immunotherapy Graft, Oncology”, Réseau épigénétique du cancéropole Grand Ouest, European University of Brittany, Brest, France
  • C. Le Dantec Research Unit EA2216 Immunology, Pathology and Immunotherapy, SFR ScinBios and Labex Igo “Immunotherapy Graft, Oncology”, Réseau épigénétique du cancéropole Grand Ouest, European University of Brittany, Brest, France
  • E. Kapsogeorgeou Department of Pathophysiology, School of Medicine, National University of Athens, 75 Mikras Asias street, Athens 11527, Greece
  • A. Bordron Research Unit EA2216 Immunology, Pathology and Immunotherapy, SFR ScinBios and Labex Igo “Immunotherapy Graft, Oncology”, Réseau épigénétique du cancéropole Grand Ouest, European University of Brittany, Brest, France
  • W.H. Brooks Department of Chemistry, University of South Florida, Tampa, Florida, USA
  • A.G. Tzioufas Department of Pathophysiology, School of Medicine, National University of Athens, 75 Mikras Asias street, Athens 11527, Greece
  • J O Pers Université de Bretagne Occidentale, Brest
  • Y. Renaudineau Laboratory of Immunology and Immunotherapy, Brest University Medical School, CHU Morvan, Brest, France

Mots-clés :

Sjögren’s syndrome, DNA methylation, HERV, epithelial cells

Résumé

Sjögren’s syndrome (SS) is a chronic autoimmune epithelitis, and several lines of experiments indicate that multifactorial factors contribute to salivary gland epithelial cells (SGEC) dysfunctions including a combination of environmental factors, lymphocytic infiltrations, genetic predispositions as well as epigenetic defects. Such statement is reinforced by the observation that global DNA methylation (5MeCyt) is altered in minor salivary glands from pSS patients and that such defect is associated cytokeratin 19 (KRT19) overexpression. An epigenetic deregulation of the KRT19 gene was further tested by treating the human salivary gland (HSG) cell line with the DNA demethylating agent 5-azacytidin, and with the histone acetylase inhibitor trichostatin A. Blocking DNA methylation, but not histone acetylation, with 5-azacytidin was associated with KRT19 overexpression at both transcriptional and protein level. Next, analysis of the CpG genome-wide methylome array in the KTR19 locus from long term cultured SGEC obtained from 8 pSS patients revealed a more reduced DNA methylation level in those patients with defective global DNA methylation. Altogether, our data, therefore, suggest that alteration of DNA methylation in SGEC may contribute to pSS pathophysiology in part by controlling the expression of KRT19.

Téléchargements

Publié-e

2016-06-28

Numéro

Vol. 53 No. 1 (2016)

Rubrique

Articles

Licence

I hereby certify that the authors of the above manuscript have all:

1. Conceived, planned, and performed the work leading to the report, or interpreted the evidence presented, or both;

2. Written the report or reviewed successive versions and shared in their revisions; and

3. Approved the final version.

Further, I certify that:

1. This work has not been published elsewhere and is not under revision in another journal;

2. Humane procedures have been followed in the treatment of experimental animals (if applicable);

3. Investigations in humans was done in accordance with the ethical standards of the responsible committee on human experimentation or with the Helsinki Declaration (if applicable).

4. This paper has been carefully read by a native English speaker who is familiar with the field of work (this applies to authors who are not fluent in English); and

5. The copyright of the article is transferred from the authors to the Bulletin du Groupement International pour la Recherche Scientifique en Stomatologie et Odontologie upon acceptance of the manuscript.